JPWO2021112106A1 - - Google Patents
Info
- Publication number
- JPWO2021112106A1 JPWO2021112106A1 JP2021562674A JP2021562674A JPWO2021112106A1 JP WO2021112106 A1 JPWO2021112106 A1 JP WO2021112106A1 JP 2021562674 A JP2021562674 A JP 2021562674A JP 2021562674 A JP2021562674 A JP 2021562674A JP WO2021112106 A1 JPWO2021112106 A1 JP WO2021112106A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/712—Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7125—Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025067241A JP2025114590A (ja) | 2019-12-02 | 2025-04-16 | 色素性乾皮症ｆ群治療薬 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019218038 | 2019-12-02 | ||
| PCT/JP2020/044768 WO2021112106A1 (ja) | 2019-12-02 | 2020-12-02 | 色素性乾皮症ｆ群治療薬 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025067241A Division JP2025114590A (ja) | 2019-12-02 | 2025-04-16 | 色素性乾皮症ｆ群治療薬 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2021112106A1 true JPWO2021112106A1 (https=) | 2021-06-10 |
Family
ID=76221697
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562674A Pending JPWO2021112106A1 (https=) | 2019-12-02 | 2020-12-02 | |
| JP2025067241A Pending JP2025114590A (ja) | 2019-12-02 | 2025-04-16 | 色素性乾皮症ｆ群治療薬 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025067241A Pending JP2025114590A (ja) | 2019-12-02 | 2025-04-16 | 色素性乾皮症ｆ群治療薬 |
Country Status (3)
| Country | Link |
|---|---|
| JP (2) | JPWO2021112106A1 (https=) |
| TW (1) | TW202134438A (https=) |
| WO (1) | WO2021112106A1 (https=) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08510130A (ja) * | 1993-05-11 | 1996-10-29 | ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル | 異常スプライシングを阻害するアンチセンスオリゴヌクレオチドと同物質の利用法 |
| JP2017519766A (ja) * | 2014-06-16 | 2017-07-20 | ユニバーシティ・オブ・サザンプトン | イントロン保持の減少 |
-
2020
- 2020-12-02 TW TW109142335A patent/TW202134438A/zh unknown
- 2020-12-02 JP JP2021562674A patent/JPWO2021112106A1/ja active Pending
- 2020-12-02 WO PCT/JP2020/044768 patent/WO2021112106A1/ja not_active Ceased
-
2025
- 2025-04-16 JP JP2025067241A patent/JP2025114590A/ja active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08510130A (ja) * | 1993-05-11 | 1996-10-29 | ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル | 異常スプライシングを阻害するアンチセンスオリゴヌクレオチドと同物質の利用法 |
| JP2017519766A (ja) * | 2014-06-16 | 2017-07-20 | ユニバーシティ・オブ・サザンプトン | イントロン保持の減少 |
Non-Patent Citations (3)
| Title |
|---|
| "PARK J. E., et al., In Vitro Modulation of Endogenous Alternative Splicing Using Splice-Switching An", METHODS IN MOLECULAR BIOLOGY, vol. 1648, JPN6021005032, 2017, pages 39 - 52, ISSN: 0005505298 * |
| "千住千佳子他, 日本人の色素性乾皮症XP-F群における新たな疾患責任遺伝子変異の同定", 生命科学系学会合同年次大会, JPN6021005031, 2017, pages 1 - 039, ISSN: 0005505297 * |
| MARIN M., ET AL., FUNCTIONAL COMPARISON OF XPF MISSENSE MUTATIONS ASSOCIATED TO MULTIPLE DNA REPAIR, GENES, vol. 10, JPN6021005033, 17 January 2019 (2019-01-17), pages 60 - 1, ISSN: 0005404784 * |
Also Published As
| Publication number | Publication date |
|---|---|
| TW202134438A (zh) | 2021-09-16 |
| JP2025114590A (ja) | 2025-08-05 |
| WO2021112106A1 (ja) | 2021-06-10 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20220601 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20220601 Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20220531 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20231018 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240830 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20241025 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20250117 |